Serum levels of the adipokine adipocyte fatty acid binding protein are decreased in chronic pancreatitis
L Selig, T Ebert, M Reiche, K Kley, U Lößner, J Kratzsch, M Blüher, M Stumvoll, H Bödeker, J Mössner, M Fasshauer · Diabetologie und Stoffwechsel · 2011 · Heft 05
Bibliografische Angaben
Zusammenfassung
Objective: Chronic pancreatitis (CP) is associated with an increased risk for diabetes mellitus and vascular complications. Adipocyte fatty acid binding protein (AFABP) was recently introduced as a novel adipokine serum levels of which were independently associated with the development of the metabolic syndrome and cardiovascular diseases in humans. In the current study, we investigated for the first time serum AFABP levels in CP patients as compared with controls. Patients and measurements: AFABP was determined by ELISA in control (n=60) and diabetic, as well as non-diabetic CP (n=60) patients and correlated to…
